The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
S2,3PSA% as a predictor of reclassification of 1st protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study.
 
Takuma Kato
No Relationships to Disclose
 
Tohru Yoneyama
No Relationships to Disclose
 
Shingo Hatakeyama
No Relationships to Disclose
 
Yoichiro Tohi
No Relationships to Disclose
 
Ryuji Matsumoto
No Relationships to Disclose
 
Takuma Sato
No Relationships to Disclose
 
Katsuyoshi Hashine
No Relationships to Disclose
 
Takahiro Kimura
No Relationships to Disclose
 
Toshiki Tanikawa
No Relationships to Disclose
 
Takayuki Goto
Research Funding - AstraZeneca
 
Masaharu Inoue
No Relationships to Disclose
 
Kohei Hashimoto
No Relationships to Disclose
 
Chikara Ohyama
No Relationships to Disclose
 
Mikio Sugimoto
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Japan; Janssen; Nippon Shinyaku; Novartis; Pfizer; Takeda
 
PRIAS-JAPAN
No Relationships to Disclose